Investor

Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.

Dr Mohammad Adib Khumaidi, president of the Indonesian Medical Association, says industry collaboration is necessary during this "new technologic era" to further digital adoption and improve the medical provider and patient experience.  

The telehealth company is also betting on secondary care.

The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.

The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.

The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.

The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.

The healthcare system became a strategic investor in the Boston-based company and will utilize Laudio to enhance worker efficiency and engagement.

The digital therapeutics company and virtual chronic pain-management program will combine their offerings to create a digital care-management solution for chronic pain.